Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Completed

Phase N/A Results

Summary of Purpose

Non-interventional, observational study of physicians' use of Dabigatran etexilate for stroke prevention in patients with atrial fibrillation and mild to moderate renal impairment

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 June 2014.

1 Oct 2012 2 Nov 2012 1 Jun 2013 1 Jun 2013 1 Jun 2014 30 Jun 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts